Evidence-based·Last reviewed May 31, 2026·How we grade evidence

Mixed Carotenoids

PhytochemicalMixed

A category, not a single nutrient. Whole-food carotenoid intake (deeply colored vegetables) is consistently linked to better health. Isolated mixed-carotenoid supplements have a much weaker case — and the historical lessons of beta-carotene in smokers are essential before recommending them.

Quick decision guide

May help most

Adults with low intake of colorful vegetables who want a carotenoid backup; people taking AREDS2 formulas for intermediate-stage age-related macular degeneration.

Common dosing range

6–15 mg/day mixed carotenoids in general supplements; AREDS2 uses 10 mg lutein + 2 mg zeaxanthin specifically for AMD.

When to expect effects

Weeks for serum carotenoid markers; months-to-years for clinical eye-disease endpoints.

Watch out for

Avoid beta-carotene supplements at >5 mg/day if you smoke or used to smoke — two large RCTs showed increased lung cancer with isolated high-dose beta-carotene in this group.

Evidence snapshot

AMD progression (AREDS2 L/Z formula)Moderate

Whole-food carotenoid intake (observational)Moderate

Cancer preventionLow

Beta-carotene supplement in smokers (HARM)Strong harm signal

What is it

Mixed carotenoids are blends of natural tetraterpenoid pigments — typically beta-carotene plus alpha-carotene, gamma-carotene, lycopene, lutein, zeaxanthin, and cryptoxanthin — derived from Dunaliella salina algae, palm fruit, or vegetable concentrates. The combination is used to mimic the diversity of carotenoids found in whole foods rather than supplying a single isolated form.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You have intermediate-stage AMD and your ophthalmologist recommends an AREDS2 formula — use the lutein/zeaxanthin version, not the original AREDS beta-carotene version

Your diet has very few colorful vegetables and you want a backup source of plant pigments

You're a healthy non-smoker looking for a modest dietary-pattern booster rather than a high-dose intervention

Probably skip if…

You smoke or quit within the last 10–15 years — avoid high-dose beta-carotene (>5 mg/day) supplements; the harm signal from ATBC/CARET is real

You're hoping to prevent cancer with high-dose isolated carotenoid supplements — the trial evidence is null or harmful

You eat a varied diet rich in carrots, leafy greens, tomatoes, sweet potato, and squash — you're already covered

You're chasing 'antioxidant' marketing claims that don't translate into clinical outcomes

Evidence at a glance

Goal	Effect	Best fit	Time
Lung cancer prevention (smokers / former smokers) — NOT recommended Strong Evidence	+16% to +28% lung cancer incidence; +8% to +17% total mortality — at 20–30 mg/day isolated synthetic beta-carotene in smokers	(N/A — this is a harm finding) Anyone who currently smokes or quit within the last 10–15 years	Harm signal apparent within 5–8 years of supplementation
Age-related macular degeneration (AMD) progression — AREDS2 formula Good Evidence	15% reduction in progression to late AMD over 10 years vs the beta-carotene AREDS formula; ~25% reduction vs no supplement (based on combined AREDS/AREDS2 data)	Adults with intermediate-stage AMD (drusen) or late AMD in one eye, particularly smokers/ex-smokers who should avoid the original beta-carotene formula	Years (slowing of progression measured at 5 and 10 years)
General antioxidant / 'cellular protection' (marketing claim) Mixed Evidence	No mortality or major-disease-incidence benefit in randomized trials	(None — better to get carotenoids from a varied diet)	Not established for general wellness endpoints

Lung cancer prevention (smokers / former smokers) — NOT recommended

Strong Evidence

Effect: +16% to +28% lung cancer incidence; +8% to +17% total mortality — at 20–30 mg/day isolated synthetic beta-carotene in smokers
Best fit: (N/A — this is a harm finding) Anyone who currently smokes or quit within the last 10–15 years
Time: Harm signal apparent within 5–8 years of supplementation

Age-related macular degeneration (AMD) progression — AREDS2 formula

Good Evidence

Effect: 15% reduction in progression to late AMD over 10 years vs the beta-carotene AREDS formula; ~25% reduction vs no supplement (based on combined AREDS/AREDS2 data)
Best fit: Adults with intermediate-stage AMD (drusen) or late AMD in one eye, particularly smokers/ex-smokers who should avoid the original beta-carotene formula
Time: Years (slowing of progression measured at 5 and 10 years)

General antioxidant / 'cellular protection' (marketing claim)

Mixed Evidence

Effect: No mortality or major-disease-incidence benefit in randomized trials
Best fit: (None — better to get carotenoids from a varied diet)
Time: Not established for general wellness endpoints

Evidence for 3 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Lung cancer prevention (smokers / former smokers) — NOT recommended

Strong Evidence

This is the most important negative finding in carotenoid supplementation. ATBC (1994, 29,133 male Finnish smokers, 20 mg/day beta-carotene) found a 16% increase in lung cancer and 8% increase in total mortality vs placebo. CARET (1996, 18,314 smokers + asbestos-exposed workers, 30 mg/day beta-carotene + retinol) found a 28% increase in lung cancer and 17% increase in total mortality, leading to early trial termination. The harm appears specific to isolated high-dose synthetic beta-carotene in current/recent smokers — not dietary carotenoids from food.

Effect size

+16% to +28% lung cancer incidence; +8% to +17% total mortality — at 20–30 mg/day isolated synthetic beta-carotene in smokers

Time to effect

Harm signal apparent within 5–8 years of supplementation

Best fit

(N/A — this is a harm finding) Anyone who currently smokes or quit within the last 10–15 years

Less likely

Healthy non-smokers do not appear to have this harm signal but also no clear benefit

Bottom line: Smokers and former smokers should avoid isolated beta-carotene supplements >5 mg/day. Choose lutein/zeaxanthin formulations if AREDS2 is medically indicated.

SourceATBC Cancer Prevention Study Group, 1994 — NEJM — alpha-tocopherol/beta-carotene trial Omenn et al., 1996 — CARET trial — NEJM — Carotene And Retinol Efficacy Trial Satia et al., 2009 — VITAL cohort — PMC — Am J Epidemiol

Age-related macular degeneration (AMD) progression — AREDS2 formula

Disease adjunct

Good Evidence

The AREDS2 trial (10-year follow-up published 2022 in JAMA Ophthalmology) showed that the lutein/zeaxanthin version of the AMD formula (10 mg lutein + 2 mg zeaxanthin) reduced progression to late AMD by 15% vs the original beta-carotene-containing formula (HR 0.85, 95% CI 0.73–0.98, P=0.02), with no increase in lung cancer risk over 10 years. This is the strongest clinical-outcome evidence for any mixed-carotenoid intervention. It applies specifically to people with intermediate-stage AMD or late AMD in one eye — not general vision protection.

Effect size

15% reduction in progression to late AMD over 10 years vs the beta-carotene AREDS formula; ~25% reduction vs no supplement (based on combined AREDS/AREDS2 data)

Time to effect

Years (slowing of progression measured at 5 and 10 years)

Best fit

Adults with intermediate-stage AMD (drusen) or late AMD in one eye, particularly smokers/ex-smokers who should avoid the original beta-carotene formula

Less likely

Healthy adults with no AMD; early AMD before drusen — AREDS2 did not show benefit at the early stage

Bottom line: The L/Z version of AREDS2 is the carotenoid intervention with the best clinical-outcome evidence. Use it on ophthalmology's recommendation, not as general 'eye vitamin' supplementation.

SourceChew et al., 2022 — AREDS2 Report 28 (10-year follow-up) — JAMA Ophthalmology

General antioxidant / 'cellular protection' (marketing claim)

Mixed Evidence

Mechanistic data (radical scavenging in vitro, increased serum carotenoid levels) does not translate into clinical outcomes in well-conducted trials. Repeated meta-analyses (including the Bjelakovic et al. Cochrane antioxidant review) have found no mortality benefit and possibly modest harm from high-dose isolated antioxidant supplementation. 'Mixed carotenoids' marketing trades on the mechanistic story without the clinical-endpoint evidence.

Effect size

No mortality or major-disease-incidence benefit in randomized trials

Time to effect

Not established for general wellness endpoints

Best fit

(None — better to get carotenoids from a varied diet)

Less likely

Anyone hoping high-dose isolated supplements will deliver the benefits seen with dietary patterns rich in colorful plants

Bottom line: Eat the colors of vegetables. Don't pay for high-dose isolated carotenoid mixes to chase 'antioxidant' marketing.

SourceNIH ODS — Vitamin A and Carotenoids (Health Professional) — NIH Office of Dietary Supplements

How to take it

1. Typical dose

• AREDS2 formula (under ophthalmology guidance): 10 mg lutein + 2 mg zeaxanthin + 500 mg vitamin C + 400 IU vitamin E + 80 mg zinc + 2 mg copper • General mixed-carotenoid supplement: 6–15 mg total carotenoids/day, preferably food-derived • Smokers/ex-smokers: keep total beta-carotene from supplements under 5 mg/day

2. Higher studied dose

Beta-carotene at 20–30 mg/day was studied in ATBC/CARET — and caused harm in smokers. Do not exceed these doses for beta-carotene specifically. Lutein up to 20 mg/day has been studied without safety signals.

3. Timing

Take with a meal containing some fat — carotenoids are fat-soluble and absorption increases 2–6× with even a few grams of dietary fat.

4. With food

With food, especially with some fat (avocado, olive oil, eggs, nuts).

5. Split dosing

Single daily dose with a meal is fine. For high lutein doses (>20 mg) splitting between meals may improve total absorption.

6. How long to try

Months for serum carotenoid and macular pigment density to plateau. Clinical eye-disease endpoints (AMD) measured over years. For general use, reassess intake annually — or stop if dietary pattern improves.

What to track

AMD progression on retinal exam if using AREDS2 (your ophthalmologist will track this)

Skin yellowing (carotenodermia) — harmless cosmetic signal of high carotenoid intake; resolves on dose reduction

Smoking history — re-evaluate beta-carotene intake if smoking status changes

Macular pigment optical density (specialty eye-clinic measurement, optional)

Bottom line: Whole-food carotenoids are best. Use AREDS2 (lutein/zeaxanthin version) only for diagnosed intermediate-stage AMD. Smokers must avoid high-dose isolated beta-carotene.

5 commercial forms

Compare the main delivery options and what they’re best suited for.

Natural mixed carotenoids (Dunaliella salina algae)

Closest to food-derived

Algae-sourced mix delivering beta-carotene, alpha-carotene, lutein, zeaxanthin, and cryptoxanthin in roughly food-like proportions. Generally preferred over synthetic beta-carotene given the historical safety signal of the synthetic form.

Naturally occurring isomer mix; similar absorption to food carotenoids.

Lutein + zeaxanthin (free form or esters)

Eye-health specific

The carotenoids that concentrate in the macula. AREDS2 used 10 mg/day lutein + 2 mg/day zeaxanthin. Lutein esters require pancreatic hydrolysis; free-form lutein is absorbed slightly faster.

Free-form has faster onset; esters reach similar steady-state.

Synthetic beta-carotene (isolated)

Avoid in smokers

The form used in ATBC and CARET. Caused increased lung cancer at 20–30 mg/day in smokers. If your supplement uses synthetic beta-carotene and you've ever smoked, consider an alternative formulation.

Mostly all-trans isomer; absorbed similarly to natural beta-carotene.

Lycopene (tomato-derived)

Prostate marketing claim

The dominant carotenoid in tomatoes. Observational data suggest possible benefit for prostate cancer; randomized trial data are mixed and don't confirm a clinical advantage of supplements over dietary tomato/lycopene intake.

Heat processing (cooked tomato, paste) markedly increases bioavailability.

Astaxanthin (algae or yeast-derived)

Marketed for skin/eye

Red carotenoid from Haematococcus algae. Smaller evidence base than lutein/zeaxanthin; some small trials suggest skin elasticity or eye fatigue benefit, but clinical impact is modest and the data quality is limited.

Highly bioavailable with fat; typically 4–12 mg/day in trials.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

carotenodermia (yellow-orange skin discoloration; harmless and reversible)rare GI upset

Serious risks

Isolated high-dose beta-carotene (≥20 mg/day) significantly increases lung cancer and total mortality in current and former smokers. Two large RCTs (ATBC, CARET) confirmed this independently.
SourceATBC Cancer Prevention Study Group, 1994 — NEJM — alpha-tocopherol/beta-carotene trial Omenn et al., 1996 — CARET trial — NEJM — Carotene And Retinol Efficacy Trial
Long-term high-dose supplementation may interact with provitamin A metabolism, especially in pregnant women — avoid retinol-equivalent total intakes above 3,000 mcg/day RAE from any source in pregnancy due to teratogenicity risk (this is retinol, not beta-carotene).
SourceNIH ODS — Vitamin A and Carotenoids (Health Professional) — NIH Office of Dietary Supplements

Who should avoid it

Current smokers — avoid beta-carotene supplements >5 mg/day. Use lutein/zeaxanthin formulations if AREDS2 is medically indicated.
SourceATBC Cancer Prevention Study Group, 1994 — NEJM — alpha-tocopherol/beta-carotene trial Omenn et al., 1996 — CARET trial — NEJM — Carotene And Retinol Efficacy Trial
Former smokers (quit <10–15 years ago) — the lung cancer signal from ATBC/CARET appears to persist for years after quitting.
SourceChew et al., 2022 — AREDS2 Report 28 (10-year follow-up) — JAMA Ophthalmology
People with asbestos exposure history — CARET specifically enrolled this group and found similar harm.
SourceOmenn et al., 1996 — CARET trial — NEJM — Carotene And Retinol Efficacy Trial
People with carotenoid metabolism disorders (rare).
SourceNIH ODS — Vitamin A and Carotenoids (Health Professional) — NIH Office of Dietary Supplements

Pregnancy & breastfeeding

Dietary carotenoids and low-to-moderate supplemental doses are considered safe in pregnancy. Avoid combination products that include preformed vitamin A (retinol) above 3,000 mcg RAE/day due to teratogenicity. Beta-carotene itself does not have a teratogenicity signal at standard supplemental doses.

SourceNIH ODS — Vitamin A and Carotenoids (Health Professional) — NIH Office of Dietary Supplements

Bottom line: The harm signal is highly specific: high-dose isolated beta-carotene in smokers. Lutein/zeaxanthin formulations and dietary carotenoid intake are safe for the general population.

Interactions

tobacco use (current or recent smoking)Major

Although not a 'drug interaction' in the classical sense, smoking dramatically changes the safety profile of supplemental beta-carotene — increasing lung cancer risk at high doses.

SourceATBC Cancer Prevention Study Group, 1994 — NEJM — alpha-tocopherol/beta-carotene trial Omenn et al., 1996 — CARET trial — NEJM — Carotene And Retinol Efficacy Trial

orlistat (weight-loss drug)Moderate

Orlistat reduces absorption of fat-soluble vitamins and carotenoids by ~30%. Take fat-soluble supplements at least 2 hours apart from orlistat doses.

SourceNIH ODS — Vitamin A and Carotenoids (Health Professional) — NIH Office of Dietary Supplements

bile acid sequestrants (cholestyramine, colestipol)Moderate

These drugs reduce intestinal absorption of fat-soluble vitamins and carotenoids. Take carotenoid supplements at least 4 hours apart from these medications.

statins (high-dose)Minor

Statins can modestly lower serum beta-carotene and lutein levels; clinical relevance is unclear. No dose-separation needed.

Food sources

Food	Amount	%DV
Sweet potato, baked (β-carotene)	1 medium (1,403 mcg RAE)	156%
Carrots, raw (β-carotene)	1 cup (1,069 mcg RAE)	119%
Spinach, boiled (lutein/zeaxanthin)	½ cup (12 mg lutein/zeaxanthin)	—
Kale, raw (lutein/zeaxanthin)	1 cup (5 mg lutein/zeaxanthin)	—
Tomato paste, canned (lycopene)	¼ cup (16 mg lycopene)	—
Watermelon, raw (lycopene)	1 cup diced (7 mg lycopene)	—
Egg yolks (lutein/zeaxanthin)	1 large (0.25 mg)	—
Pumpkin, canned (β-carotene)	½ cup (953 mcg RAE)	106%
Mango, raw (β-carotene)	1 cup sliced (89 mcg RAE)	10%
Bell pepper, red, raw (β-cryptoxanthin)	1 cup (117 mcg RAE)	13%

Sweet potato, baked (β-carotene)

Amount: 1 medium (1,403 mcg RAE)
%DV: 156%

Carrots, raw (β-carotene)

Amount: 1 cup (1,069 mcg RAE)
%DV: 119%

Spinach, boiled (lutein/zeaxanthin)

Amount: ½ cup (12 mg lutein/zeaxanthin)
%DV: —

Kale, raw (lutein/zeaxanthin)

Amount: 1 cup (5 mg lutein/zeaxanthin)
%DV: —

Tomato paste, canned (lycopene)

Amount: ¼ cup (16 mg lycopene)
%DV: —

Watermelon, raw (lycopene)

Amount: 1 cup diced (7 mg lycopene)
%DV: —

Egg yolks (lutein/zeaxanthin)

Amount: 1 large (0.25 mg)
%DV: —

Pumpkin, canned (β-carotene)

Amount: ½ cup (953 mcg RAE)
%DV: 106%

Mango, raw (β-carotene)

Amount: 1 cup sliced (89 mcg RAE)
%DV: 10%

Bell pepper, red, raw (β-cryptoxanthin)

Amount: 1 cup (117 mcg RAE)
%DV: 13%

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for…

Carotenoid sources clearly listed by individual compound (lutein, zeaxanthin, beta-carotene, lycopene, etc.) with mg each — not a 'proprietary blend'

Beta-carotene clearly identified as 'natural mixed carotenoids' (from Dunaliella algae, palm fruit) rather than synthetic beta-carotene — the natural source is the form used in most positive observational studies

AREDS2 formulas: 10 mg lutein + 2 mg zeaxanthin per dose, with the rest of the AREDS2 stack (C, E, zinc, copper) — used only for diagnosed intermediate AMD

Third-party tested (USP, NSF, ConsumerLab)

No added preformed vitamin A (retinyl palmitate) in pregnancy-marketed products at doses >3,000 mcg RAE/day total

Be skeptical of…

'Cancer prevention' or 'anti-cancer antioxidant' claims — RCTs have not confirmed this and showed harm in smokers with isolated beta-carotene

Mega-dose products (25,000+ IU as beta-carotene = 15+ mg) marketed for general wellness, especially without smoker warnings

'Eye health' formulas that aren't actually the AREDS2 dose/composition — many shortcut products under-dose lutein/zeaxanthin

Combination products with preformed retinol at high doses marketed for women of reproductive age

Cosmetic 'inner tan' / skin-coloring supplements at high beta-carotene doses for non-medical use

References by claim

Age-related macular degeneration (AMD) progression — AREDS2 formula

Chew et al., 2022 — AREDS2 Report 28 (10-year follow-up) — JAMA Ophthalmology (2022) link

General antioxidant / 'cellular protection' (marketing claim)

NIH ODS — Vitamin A and Carotenoids (Health Professional) — NIH Office of Dietary Supplements (2024) link

Lung cancer prevention (smokers / former smokers) — NOT recommended

ATBC Cancer Prevention Study Group, 1994 — NEJM — alpha-tocopherol/beta-carotene trial (1994) link

Omenn et al., 1996 — CARET trial — NEJM — Carotene And Retinol Efficacy Trial (1996) link

Satia et al., 2009 — VITAL cohort — PMC — Am J Epidemiol (2009) link

Track Mixed Carotenoids with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store

Evidence-based·Last reviewed May 31, 2026·Evidence current as of May 31, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.